CCL2 and cancer: Our findings demonstrate that F. nucleatum drives the transformation of adipocytes into a cancer-associated phenotype, which subsequently promotes cisplatin resistance in necrotic lymph nodes of HNSCC through activation of the CCL2-CCR2 signaling axis.